Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Ascorbic acid derivatives improve drug delivery systems.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Certain compounds found in edible mushrooms may help treat hair loss.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.